Channel 4's "The Great ADHD Myth?": what we know and the evidence

Channel 4 has announced a new documentary called "The Great ADHD Myth?", which asks whether ADHD is a genuine neurodevelopmental disorder or a social construct. For many people with an ADHD diagnosis, that framing alone can feel distressing or invalidating. This article sets out only what Channel 4's own press release confirms about the programme, and then lays out the clinical and prevalence evidence on ADHD so readers can weigh the documentary's premise against the established research.

What Channel 4 has confirmed

According to Channel 4's press release, published on 29 July 2026, the documentary is titled "The Great ADHD Myth?". It is described as a one hour film presented by Dr Max Pemberton, directed by Xavier Alford, produced by Minnow Films, and commissioned by Tim Hancock. Channel 4's press release states that the documentary asks whether ADHD is a genuine neurodevelopmental disorder or a social construct.

The press release also confirms that Channel 4 is using NHS England's ADHD Management Information, published in November 2025, as its data source for discussing rising ADHD diagnosis rates. No broadcast or transmission date was confirmed in the press release, so none is stated here. No response from the Royal College of Psychiatrists to the documentary has been located, so none is attributed to them in this piece.

Why the framing matters

Presenting ADHD's status as an open question, "genuine disorder or social construct", is a stronger and more contested framing than the current clinical and scientific position on ADHD, which is set out below. It is reasonable for people with ADHD, and their families, to find a national broadcaster asking this question distressing, particularly if they have gone through a lengthy and difficult process to obtain a diagnosis. Acknowledging that reaction is not the same as agreeing or disagreeing with the documentary's conclusions, which have not yet been broadcast or reviewed at the time of writing.

What the clinical guidance says

NICE guideline NG87 is the UK clinical guideline covering the diagnosis and management of ADHD. It treats ADHD as a recognised neurodevelopmental condition with formal diagnostic criteria, and it sets out structured assessment and management pathways for children, young people and adults. NICE guidelines are produced through a formal evidence review process, and NG87 represents the current UK clinical consensus that ADHD is a genuine, diagnosable condition, not a matter still under open scientific dispute at the level Channel 4's title implies.

What the prevalence evidence shows

Separately from clinical guidance, a large umbrella review of meta-analyses, published in October 2023, found the global prevalence of ADHD in children and adolescents to be 8.0% (95% confidence interval 6.0% to 10%). This figure is drawn from 13 meta-analyses covering 588 primary studies and over 3.2 million participants, using consistent diagnostic and screening methods across many countries and decades. A condition that were purely a social construct with no underlying basis would be unlikely to produce such a consistent prevalence estimate across such a broad and methodologically varied body of research.

What is actually rising: diagnosis and referral activity

Channel 4's press release cites NHS England Digital's ADHD Management Information, published November 2025, as its source on rising diagnosis rates. This official England data does track a real and substantial rise in referral, diagnosis and prescribing activity for ADHD. That rise in system activity is a genuine and well-documented trend. However, a rise in diagnosis activity is not itself evidence about whether ADHD is a valid condition; it is evidence about how many people are being recognised, referred and assessed within the health system. Confusing the two, treating "more diagnoses" as evidence for "maybe ADHD isn't real", conflates two different kinds of data. The prevalence research and the diagnosis activity data measure different things, and only the former speaks to how common ADHD actually is.

Holding two things at once

It is possible to hold both of the following at once:

• Genuine questions exist and are actively discussed in the scientific and clinical literature about how ADHD is best identified, whether current diagnostic thresholds are optimal, and how services should be organised to meet need, including the scale of demand reflected in NHS England's own data.
• None of the sources reviewed for this article, including NICE's own guideline and the peer-reviewed prevalence literature, treat ADHD's basic validity as a genuine neurodevelopmental condition as an open question in the way the documentary's title suggests.

A documentary that asks a provocative question in its title does not necessarily reach a provocative conclusion, and no broadcast has taken place at the time of writing, so its actual content and conclusions cannot yet be assessed here.

What to do if this coverage is unsettling

If seeing headlines or a documentary title questioning ADHD's validity is distressing, it may help to remember that a diagnosis, if you have one, was made through the structured process set out in NICE guideline NG87, following an assessment by a qualified clinician. Media coverage, however framed, does not change that clinical process or its evidence base. If you have concerns about your own diagnosis or care, the appropriate step is to speak to your GP or the clinician who assessed you, not to draw conclusions from a documentary before it has aired.

ADHD Tribe provides non-clinical coaching for adults with ADHD and does not diagnose or treat the condition. We will continue to report on this documentary and any further confirmed details as they become available, using only verified sources.

Reporting on this responsibly

Because no broadcast date has been confirmed and the documentary has not yet aired, this article deliberately limits itself to what Channel 4's press release states, rather than speculating about the documentary's likely conclusions, tone or reception. Speculation ahead of broadcast risks either overstating concern about a programme that has not yet been seen, or understating a genuinely difficult question that deserves careful public discussion once the actual content is available for scrutiny.

What responsible coverage of ADHD looks like

Whatever the documentary eventually shows, questions about how a condition is diagnosed, how services are organised and how demand should be managed can be asked and discussed without questioning whether people with a genuine ADHD diagnosis are being truthful about their own experience. The evidence reviewed in this article, NICE guideline NG87's formal diagnostic framework and the consistent prevalence estimates from a large, methodologically rigorous umbrella review, provides a way of testing any claims made in the documentary once it airs, against an established evidence base rather than against opinion alone.

Checking back after broadcast

Readers who want to understand the documentary's actual arguments and evidence, once broadcast, should look for coverage that reports what was actually said and shown, checked where possible against the sources referenced in this article, including NICE guideline NG87 and the peer-reviewed prevalence literature. This article will be a starting point on the confirmed facts around the announcement, not a review of content that has not yet been broadcast.

Why documentary titles matter, even before broadcast

A title such as "The Great ADHD Myth?" is doing a lot of work before a single frame has aired. It signals to viewers, and to anyone sharing the announcement on social media, that the underlying validity of ADHD is up for debate. This can shape public perception regardless of what the eventual documentary actually concludes, since headlines and trailers often reach far more people than the full programme itself. It is worth separating the marketing framing of a title from the actual content of a documentary, which cannot be assessed until it has been broadcast and reviewed.

This is not a criticism of documentary-makers exploring difficult territory; provocative titles are a common feature of factual broadcasting used to attract an audience. But for a condition where diagnosis already involves long waiting lists and, for some, years of feeling unheard, a title questioning basic legitimacy can land differently.

What to look out for when the documentary airs

If the documentary is broadcast, it is worth reading its actual content carefully, rather than relying on the title or early publicity alone. Questions worth holding in mind include: does the documentary distinguish between genuine, evidence-based debates within the field, such as how diagnostic thresholds are set or how services should be organised to meet demand, and a much stronger claim that ADHD itself may not be a real condition. Does it engage with the structured evidence base described in NICE guideline NG87 and the peer-reviewed prevalence literature, or does it rely mainly on anecdote and rising diagnosis figures. These are reasonable questions to bring to any documentary on a clinical topic, not just this one.

A note for people who already have a diagnosis

If you already have an ADHD diagnosis, obtained through the structured assessment process set out in NICE guideline NG87, a television documentary questioning ADHD's validity does not change the basis on which that diagnosis was made. Your diagnosis was reached by a qualified clinician applying formal diagnostic criteria, not by public debate. It is understandable to feel unsettled seeing your condition's legitimacy questioned on television, and you are not obliged to engage with the documentary or resulting online discussion if you would rather not.

If you are trying to make sense of the wider debate

For anyone trying to understand the broader debate about rising ADHD diagnoses, it can help to keep two questions apart: first, "is ADHD a genuine condition", which is answered by the clinical and scientific evidence summarised above, and second, "is the current diagnosis and referral system in England working well, and coping with demand", which is a legitimate and separate question about health service capacity, reflected in NHS England's own published data on referral and waiting numbers. Conflating these two, treating pressure on services as evidence against the condition, is a common but mistaken way of reading the data.

Where to go for reliable information

If a documentary, a news story or a social media post about ADHD leaves you with questions about your own diagnosis, medication or care, the appropriate people to ask are your GP or the clinician managing your care, not a television programme, however well produced. NICE guideline NG87 remains the current UK clinical guideline on diagnosis and management, and it is publicly available for anyone who wants to read the primary source rather than relying on secondary reporting.

References

• Channel 4 press release, 29 July 2026, "New Channel 4 documentary The Great ADHD Myth? seeks to determine whether ADHD is genuine"
• NICE guideline NG87, Attention deficit hyperactivity disorder: diagnosis and management
• Umbrella review of meta-analyses, global ADHD prevalence in children and adolescents
• NHS England Digital, ADHD Management Information, November 2025